Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Completed · Phase 1/Phase 2

Conditions studied: Bladder Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of paclitaxel in treating patients with early-stage bladder cancer.

Key facts

Study ID

NCT00002917

Run by

Mary Babb Randolph Cancer Center at West Virginia University Hospitals

Starts

1996-11-01

Expected to finish

2004-05-01

Last updated by the study team

2013-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• West Virginia University Hospitals — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.